GfK U.S. Healthcare Companies LP Sustainability Profile
GfK U.S. Healthcare Companies LP, a prominent player in the healthcare analytics sector, is headquartered in the United States. Founded in 1934, the company has established itself as a leader in providing data-driven insights and market research tailored for the healthcare industry. With a strong presence across major operational regions in North America, GfK focuses on delivering innovative solutions that enhance decision-making for healthcare providers, pharmaceutical companies, and payers. The company’s core offerings include advanced analytics, market access solutions, and patient engagement strategies, all designed to optimise healthcare outcomes. GfK's unique approach combines deep industry expertise with cutting-edge technology, positioning it as a trusted partner in the healthcare landscape. Notable achievements include significant contributions to market research methodologies, solidifying its reputation as a key influencer in healthcare analytics.
DitchCarbon Score
How does GfK U.S. Healthcare Companies LP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GfK U.S. Healthcare Companies LP's score of 29 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GfK U.S. Healthcare Companies LP currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of GfK SE, which may influence its climate-related strategies and commitments. While there are no documented reduction targets or climate pledges from GfK U.S. Healthcare Companies LP, emissions data may be inherited from its parent company, GfK SE, or through its corporate family relationship with Nielsen Consumer LLC, which provides data at a cascade level of 2. As of now, GfK U.S. Healthcare Companies LP has not established any significant reduction initiatives or commitments to the Science Based Targets initiative (SBTi). The lack of specific emissions data and reduction targets suggests that the company may still be in the early stages of developing its climate strategy. In the broader context of the healthcare industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious climate goals. GfK U.S. Healthcare Companies LP may need to align with these industry trends to enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 2,087,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 9,839,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 44,633,000 | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is GfK U.S. Healthcare Companies LP's Industry?
How Carbon Intensive is GfK U.S. Healthcare Companies LP's Location?
GfK U.S. Healthcare Companies LP's Scope 3 Categories Breakdown
GfK U.S. Healthcare Companies LP's Scope 3 emissions, which increased by 13% last year and decreased by approximately 65% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 71% of total emissions under the GHG Protocol, with "Employee Commuting" being the largest emissions source at 52% of Scope 3 emissions.
Top Scope 3 Categories
GfK U.S. Healthcare Companies LP's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GfK U.S. Healthcare Companies LP has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
